These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8475637)
41. Care of insulin-dependent diabetics. Fisher M Practitioner; 1991 Oct; 235(1507):783-5. PubMed ID: 1800985 [No Abstract] [Full Text] [Related]
42. [Diabetes in children. 2. The insulins]. Levy-Marchal C Soins Gynecol Obstet Pueric Pediatr; 1986 Mar; (58):3-6. PubMed ID: 3520900 [No Abstract] [Full Text] [Related]
43. A patient requiring 1,000 units of insulin per day! Raal FJ; Pieterse A S Afr Med J; 2000 Apr; 90(4):357-8. PubMed ID: 10957917 [No Abstract] [Full Text] [Related]
44. [Functional hypoglycemia: a trial of treatment with phenytoin. Effects on blood sugar and blood insulin curves]. Mirouze J; Collard F; Thuan CD Therapie; 1976; 31(5):605-13. PubMed ID: 1013952 [No Abstract] [Full Text] [Related]
45. [Change in circadian secretion of cortisol in some diabetic patients: clinical and therapeutic implications]. Enríquez-Acosta L; Hernández Cruz JM; Madrid JA; Salido GM Rev Clin Esp; 1987 Mar; 180(5):238-41. PubMed ID: 3299536 [No Abstract] [Full Text] [Related]
46. Insulin treatment: a decade of change. Home PD; Thow JC; Tunbridge FK Br Med Bull; 1989 Jan; 45(1):92-110. PubMed ID: 2676076 [TBL] [Abstract][Full Text] [Related]
47. Modern management of insulin-dependent diabetes mellitus. Nathan DM Med Clin North Am; 1988 Nov; 72(6):1365-78. PubMed ID: 3054358 [TBL] [Abstract][Full Text] [Related]
48. Devices for the treatment of diabetes: today. Scheen AJ Artif Organs; 1992 Apr; 16(2):163-6. PubMed ID: 10078238 [TBL] [Abstract][Full Text] [Related]
49. Dawn phenomena in diabetes. Lancet; 1984 Jun; 1(8390):1333-4. PubMed ID: 6145031 [No Abstract] [Full Text] [Related]
50. [Insulin--its past, present and future]. Grujić M; Hrisafović Z; Kulenović I Med Arh; 1989; 43(1):45-50. PubMed ID: 2696853 [TBL] [Abstract][Full Text] [Related]
52. The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin. Chantelau E Diabetes Care; 2006 Feb; 29(2):477; author reply 477-8. PubMed ID: 16482700 [No Abstract] [Full Text] [Related]
53. Dawn phenomenon and intensified therapy. White NH; Skor DA; Santiago JV Diabetes Care; 1983; 6(5):525-6. PubMed ID: 6400714 [No Abstract] [Full Text] [Related]
54. DIABETEX decision module 2--calculation of insulin dose proposals and situation recognition by means of classifiers. Stadelmann A; Abbas S; Zahlmann G; Bruns W; Hennig I Comput Methods Programs Biomed; 1990; 32(3-4):333-7. PubMed ID: 2249433 [TBL] [Abstract][Full Text] [Related]
55. Computer-aided systems in the management of type I diabetes: the application of a model-based strategy. Salzsieder E; Albrecht G; Fischer U; Rutscher A; Thierbach U Comput Methods Programs Biomed; 1990; 32(3-4):215-24. PubMed ID: 2249420 [TBL] [Abstract][Full Text] [Related]
56. Chronic intermittent intravenous insulin therapy: really a new therapeutic option? Heinemann L Diabetes Technol Ther; 2001; 3(1):125-7. PubMed ID: 11469702 [No Abstract] [Full Text] [Related]
57. Insulin therapy: how many injections? Stocks AE Med J Aust; 1991 Aug; 155(4):211-2. PubMed ID: 1875829 [No Abstract] [Full Text] [Related]
58. Insulin therapy development beyond 100 years. Home PD; Mehta R Lancet Diabetes Endocrinol; 2021 Oct; 9(10):695-707. PubMed ID: 34480874 [TBL] [Abstract][Full Text] [Related]
59. The role of insulin purification: an overview. Jones RL; McDermott K; Drexler A; Niquette WS; Peterson CM Diabetes Care; 1982; 5 Suppl 1():102-3. PubMed ID: 6765117 [TBL] [Abstract][Full Text] [Related]